[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 11, 2009

High-Dose B Vitamin Supplements and Alzheimer Disease

JAMA. 2009;301(10):1020-1022. doi:10.1001/jama.2009.211

To the Editor: The randomized controlled trial by Dr Aisen and colleagues1 provided evidence that treatment with high-dose B vitamin supplements for 18 months does not slow cognitive decline in individuals with mild to moderate Alzheimer disease (AD). The rationale behind the study was that hyperhomocysteinemia (levels of homocysteine >15 μmol/L) is associated with a higher risk of dementia and AD2,3 and that homocysteine levels can be reduced by use of high-dose B vitamins and folate. Thus, the study was designed to determine in patients with AD whether a regimen of high-dose B vitamins and folate would slow their cognitive decline by reducing homocysteine levels. However, despite a 20% to 25% reduction in homocysteine level and an increase in B vitamin and folate levels associated with the active treatment, the trial found no effect.

First Page Preview View Large
First page PDF preview
First page PDF preview
×